Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F McAuliffe

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Contemporary Clinical Trials|September 24, 2022
Improving well-being for individuals with persistent pain after surgery for breast cancer, lobular carcinoma in situ, or ductal carcinoma in situ: A randomized clinical trialJuliann M Stalls, Dana H Bovbjerg, Tamara J Somers, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 4, 2025
Aerobic exercise and aromatase inhibitor-associated musculoskeletal symptoms: results of a randomized clinical trialCatherine M Bender, Susan M Sereika, Amanda L Gentry, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2019
Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapyMin Han, Arsalan Salamat, Li Zhu, et al.
Cancer|April 25, 2015
Patterns of change in cognitive function with anastrozole therapyCatherine M Bender, John D Merriman, Amanda L Gentry, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumorsDaniel J Farrugia, Alessandra Landmann, Li Zhu, et al.
JAMA Network Open|April 15, 2021
Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast CancerNeil Carleton, Jian Zou, Yusi Fang, et al.
Annals of Surgical Oncology|January 3, 2025
Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or Ductal Carcinoma In Situ in Patients Diagnosed with Flat Epithelial Atypia by Core Needle Biopsy (TBCRC 034)Faina Nakhlis, Gabrielle M Baker, Tianyu Li, et al.
Nature Cancer|March 17, 2023
Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironmentSayali Onkar, Jian Cui, Jian Zou, et al.
The Lancet. Healthy Longevity|January 20, 2022
Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older womenNeil Carleton, Azadeh Nasrazadani, Kristine Gade, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
WCRC-25: A novel luminal Invasive Lobular Carcinoma cell line modelAshuvinee Elangovan, Emily A Bossart, Ahmed Basudan, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Contemporary Clinical Trials|September 24, 2022
Improving well-being for individuals with persistent pain after surgery for breast cancer, lobular carcinoma in situ, or ductal carcinoma in situ: A randomized clinical trialJuliann M Stalls, Dana H Bovbjerg, Tamara J Somers, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 4, 2025
Aerobic exercise and aromatase inhibitor-associated musculoskeletal symptoms: results of a randomized clinical trialCatherine M Bender, Susan M Sereika, Amanda L Gentry, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 7, 2019
Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapyMin Han, Arsalan Salamat, Li Zhu, et al.
Cancer|April 25, 2015
Patterns of change in cognitive function with anastrozole therapyCatherine M Bender, John D Merriman, Amanda L Gentry, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumorsDaniel J Farrugia, Alessandra Landmann, Li Zhu, et al.
JAMA Network Open|April 15, 2021
Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast CancerNeil Carleton, Jian Zou, Yusi Fang, et al.
Annals of Surgical Oncology|January 3, 2025
Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or Ductal Carcinoma In Situ in Patients Diagnosed with Flat Epithelial Atypia by Core Needle Biopsy (TBCRC 034)Faina Nakhlis, Gabrielle M Baker, Tianyu Li, et al.
Nature Cancer|March 17, 2023
Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironmentSayali Onkar, Jian Cui, Jian Zou, et al.
The Lancet. Healthy Longevity|January 20, 2022
Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older womenNeil Carleton, Azadeh Nasrazadani, Kristine Gade, et al.
Biorxiv : the Preprint Server for Biology|September 25, 2023
WCRC-25: A novel luminal Invasive Lobular Carcinoma cell line modelAshuvinee Elangovan, Emily A Bossart, Ahmed Basudan, et al.
Pageof 12